Asset Management One
AMRI

Asset Management One’s Albany Molecular Research Inc AMRI Stock Holding History

Asset Management One’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,554
Closed -$221K – 1388
2014
Q4 		$221K Sell
13,554
-45,423
-77% -$834K ﹤0.01% 1175
2014
Q3 		$1.3M Hold
58,977
– – 0.02% 733
2014
Q2 		$1.19M Hold
58,977
– – 0.02% 710
2014
Q1 		$1.1M Hold
58,977
– – 0.02% 690
2013
Q4 		$594K Buy
58,977
+9,512
+19% +$115K 0.01% 893
2013
Q3 		$638K Buy
+49,465
New +$608K 0.01% 861

Other funds holding AMRI

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Asset Management One's AMRI Position: Q1 2015 in Review

Asset Management One sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 13,554 shares — an estimated $221K sold.

Asset Management One first reported a position in AMRI in Q3 2013 and held it in 6 quarters. The position peaked at $1.3M in Q3 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

  • Asset Management One reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
  • Asset Management One sold 13,554 Albany Molecular Research Inc shares in Q1 2015, an estimated $221K.
  • Asset Management One first reported a position in Albany Molecular Research Inc in Q3 2013 and held it in 6 quarters.
  • Asset Management One's Albany Molecular Research Inc position peaked at $1.3M in Q3 2014.
  • 131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on Asset Management One's 13F filing for Q1 2015, filed 11 May 2015.